The Union Health Ministry has sought a report from Rajasthan after the WHO requested information on a possible link between suspected spurious oxytocin and complications following caesarean surgeries.
Drug regulators cancelled the licences of a Kota-based oxytocin distributor and two manufacturing units after inspections reportedly found irregularities.
Cases of post-surgery complications have been reported in Kota, Bikaner and Jodhpur, with several deaths and multiple women continuing to undergo dialysis.

